0 penilaian0% menganggap dokumen ini bermanfaat (0 suara)
124 tayangan7 halaman
Chronic follicular conjunctivitis is a mild type of chronic inflammation associated with follicular hyperplasia, predominantly involving the lower eyelid. There are several etiological types including infective, toxic, chemical, and allergic. Allergic conjunctivitis is characterized by itching and can be seasonal or perennial. Signs include conjunctival injection, edema, clear discharge, and papillae formation. Treatment involves antihistamines, mast cell stabilizers, and short term steroid drops under supervision.
Chronic follicular conjunctivitis is a mild type of chronic inflammation associated with follicular hyperplasia, predominantly involving the lower eyelid. There are several etiological types including infective, toxic, chemical, and allergic. Allergic conjunctivitis is characterized by itching and can be seasonal or perennial. Signs include conjunctival injection, edema, clear discharge, and papillae formation. Treatment involves antihistamines, mast cell stabilizers, and short term steroid drops under supervision.
Chronic follicular conjunctivitis is a mild type of chronic inflammation associated with follicular hyperplasia, predominantly involving the lower eyelid. There are several etiological types including infective, toxic, chemical, and allergic. Allergic conjunctivitis is characterized by itching and can be seasonal or perennial. Signs include conjunctival injection, edema, clear discharge, and papillae formation. Treatment involves antihistamines, mast cell stabilizers, and short term steroid drops under supervision.
It is a mild type of chronic catarrhal conjunctivitis associated with follicular hyperplasia,
predominantly involving the lower lid.
Etiological types 1. I nfective chronic follicular conjunctivitis is essentially a condition of 'benign folliculosis' with a superadded mild infection. Benign folliculosis, also called 'School folliculosis', mainly affects school children. This condition usually occurs as a part of generalized lymphoid hyperplasia of the upper respiratory tract (enlargement of adenoids and tonsils) seen at this age. It may be associated with malnutrition, constitutional disorders and unhygienic conditions. In this condition, follicles are typically arranged in parallel rows in the lower palpebral conjunctiva without any associated conjunctival hyperaemia (Fig.4.18).
2. Toxic type of chronic follicular conjunctivitis is seen in patients suffering from molluscum contagiosum. This follicular conjunctivitis occurs as a response to toxic cellular debris desquamated into the conjunctival sac from the molluscum contagiosum nodules present on the lid margin (the primary lesion).
3. Chemical chronic follicular conjunctivitis. It is an irritative follicular conjunctival response which occurs after prolonged administration of topical medication. The common topical preparations associated with chronic follicular conjunctivitis are: idoxuridine (IDU), eserine, pilocarpine, DFP and adrenaline.
4. Chronic allergic follicular conjunctivitis. A true allergic response is usually papillary. However, a follicular response is also noted in patients with 'contact dermoconjunctivitis'.
Allergic conjunctivitis HistoryThe main feature of allergic conjunctivitis is itching. Both eyes usually are affected and there may be a clear discharge. There may be a family history of atopy or recent contact with chemicals or eye drops. Similar symptoms may have occurred in the same season in previous years. It is important to differentiate between an acute allergic reaction and a more long term chronic allergic eye disease. ExaminationThe conjunctivae are diffusely injected and may be oedematous (chemosis). The discharge is clear and stringy. Because of the fibrous septa that tether the eyelid (tarsal) conjunctivae, oedema results in round swellings (papillae). When these are large they are referred to as cobblestones. ManagementTopical antihistamine and vasoconstrictor eye drops provide short term relief. Eye drops that prevent degranulation of mast cells also are useful, but they may need to be used for several weeks or months to achieve maximal effect. Oral antihistamines may also be used, particularly the newer compounds that cause less sedation. Topical steroids are effective but should not be used without regular ophthalmological supervision because of the risk of steroid induced cataracts and glaucoma, which may irreversibly
ALLERGIC CONJUNCTIVITIS It is the inflammation of conjunctiva due to allergic or hypersensitivity reactions which may be immediate (humoral) or delayed (cellular). The conjunctiva is ten times more sensitive than the skin to allergens. Types 1. Simple allergic conjunctivitis _ Hay fever conjunctivitis _ Seasonal allergic conjunctivitis (SAC) _ Perennial allergic conjunctivitis (PAC) 2. Vernal keratoconjunctivitis (VKC) 3. Atopic keratoconjunctivitis (AKC) 4. Giant papillary conjunctivitis (GPC) 5. Phlyctenular keratoconjunctivitis (PKC) 6. Contact dermoconjunctivitis (CDC)
Simple Allergic Conjunctivitis It is a mild, non-specific allergic conjunctivitis characterized by itching, hyperaemia and mild papillary response. Basically, it is an acute or subacute urticarial reaction. Etiology It is seen in following forms: 1. Hay fever conjunctivitis. It is commonly associated with hay fever (allergic rhinitis). The common allergens are pollens, grass and animal dandruff. 2. Seasonal allergic conjunctivitis (SAC). SAC is a response to seasonal allergens such as grass pollens. It is of very common occurrence. 3. Perennial allergic conjunctivitis (PAC) is a response to perennial allergens such as house dust and mite. It is not so common.
Pathology Pathological features of simple allergic conjunctivitis comprise vascular, cellular and conjunctival responses. 1. Vascular response is characterised by sudden and extreme vasodilation and increased permeability of vessels leading to exudation. 2. Cellular response is in the form of conjunctival infiltration and exudation in the discharge of eosinophils, plasma cells and mast cells producing histamine and histamine-like substances. 3. Conjunctival response is in the form of boggy swelling of conjunctiva followed by increased connective tissue formation and mild papillary hyperplasia.
Clinical picture Symptoms include intense itching and burning sensation in the eyes associated with watery discharge and mild photophobia.
Signs. (a) Hyperaemia and chemosis which give a swollen juicy appearance to the conjunctiva. (b) Conjunctiva may also show mild papillary reaction. (c) Oedema of lids.
Diagnosis Diagnosis is made from : (1) typical symptoms and signs; (2) normal conjunctival flora; and (3) presence of abundant eosinophils in the discharge.
Treatment 1. Elimination of allergens if possible. 2. Local palliative measures which provide immediate relief include: i. Vasoconstrictors like adrenaline, ephedrine, and naphazoline. ii. Sodium cromoglycate drops are very effective in preventing recurrent atopic cases. iii. Steroid eye drops should be avoided. However, these may be prescribed for short duration in severe and non-responsive patients. 3. Systemic antihistaminic drugs are useful in acute cases with marked itching. 4. Desensitization has been tried without much rewarding results. However, a trial may be given in recurrent cases.
VERNAL KERATOCONJUNCTIVITIS (VKC) OR SPRING CATARRH It is a recurrent, bilateral, interstitial, self-limiting, allergic inflammation of the conjunctiva having a periodic seasonal incidence. Etiology It is considered a hypersensitivity reaction to some exogenous allergen, such as grass pollens. VKC is thought to be an atopic allergic disorder in many cases, in which IgE-mediated mechanisms play an important role. Such patients may give personal or family history of other atopic diseases such as hay fever, asthma, or eczema and their peripheral blood shows eosinophilia and inceased serum IgE levels. Predisposing factors 1. Age and sex. 4-20 years; more common in boys than girls. 2. Season. More common in summer; hence the name spring catarrh looks a misnomer. Recently it is being labelled as 'Warm weather conjunctivitis'. 3. Climate. More prevalent in tropics, less in temperate zones and almost non-existent in cold climate.
Pathology 1. Conjunctival epithelium undergoes hyperplasia and sends downward projections into the subepithelial tissue. 2. Adenoid layer shows marked cellular infiltration by eosinophils, plasma cells, lymphocytes and histiocytes. 3. Fibrous layer shows proliferation which later on undergoes hyaline changes. 4. Conjunctival vessels also show proliferation, increased permeability and vasodilation. All these pathological changes lead to formation of multiple papillae in the upper tarsal conjunctiva.
Clinical picture Symptoms. Spring catarrh is characterised by marked burning and itching sensation which is usually intolerable and accentuated when patient comes in awarm humid atmosphere. Itching is more marked with palpebral form of disease. Other associated symptoms include: mild photophobia, lacrimation, stringy (ropy) discharge and heaviness of lids. Signs of vernal keratoconjunctivitis can be described in following three clinical forms: 1. Palpebral form. Usually upper tarsal conjunctiva of both eyes is involved. The typical lesion is may hypertrophy to produce cauliflower like excrescences of 'giant papillae'. Conjunctival changes are associated with white ropy discharge. characterized by the presence of hard, flat topped, papillae arranged in a 'cobble-stone' or 'pavement stone', fashion (Fig. 4.20). In severe cases, papillae may hypertrophy to produce cauliflower like excrescences of 'giant papillae'. Conjunctival changes are associated with white ropy discharge. Fig. 4.20. Palpebral form of vernal keratoconjunctivitis
2. Bulbar form. It is characterised by: (i) dusky red triangular congestion of bulbar conjunctiva in palpebral area; (ii) gelatinous thickened accumulation of tissue around the limbus; and (iii) presence of discrete whitish raised dots along the limbus (Tranta's spots) (Fig. 4.21).
3. Mixed form. It shows combined features of both palpebral and bulbar forms (Fig. 4.22). Vernal keratopathy. Corneal involvement in VKC may be primary or secondary due to extension of limbal lesions. Vernal keratopathy includes following 5 types of lesions: 1. Punctate epithelial keratitis involving upper cornea is usually associated with palpebral form of disease. The lesions always stain with rose bengal and invariably with fluorescein dye. 2. Ulcerative vernal keratitis (shield ulceration) presents as a shallow transverse ulcer in upper part of cornea. The ulceration results due to epithelial macroerosions. It is a serious problem which may be complicated by bacterial keratitis. 3. Vernal corneal plaques result due to coating of bare areas of epithelial macroerosions with a layer of altered exudates (Fig. 4.23). 4. Subepithelial scarring occurs in the form of a ring scar. 5. Pseudogerontoxon is characterised by a classical cupids bow outline. Fig. 4.21. Bulbar form of vernal keratoconjunctivitis
Fig. 4.22. Artist's diagram of mixed form of vernal keratoconjunctivitis.c
Fig. 4.23. Vernal corneal plaque.
Clinical course of disease is often self-limiting and usually burns out spontaneously after 5-10 years. Differential diagnosis. Palpebral form of VKC needs to be differentiated from trachoma with pre-dominant papillary hypertrophy (see page 67).
Treatment A. Local therapy 1. Topical steroids. These are effective in all forms of spring catarrh. However, their use should be minimised, as they frequently cause steroid induced glaucoma. Therefore, monitoring of intraocular pressure is very important during steroid therapy. Frequent instillation (4 hourly) to start with (2 days) should be followed by maintenance therapy for 3-4 times a day for 2 weeks. Commonly used steroid solutions are of fluorometholone medrysone, betamethasone or dexamethasone. Medrysone and fluorometholone are safest of all these. 2. Mast cell stabilizers such as sodium cromoglycate (2%) drops 4-5 times a day are quite effective in controlling VKC, especially atopic cases. It is mast cell stabilizer. Azelastine eye drops are also effective in controlling VKC. 3. Topical antihistaminics are also effective. 4. Acetyl cysteine (0.5%) used topically has mucolytic properties and is useful in the treatment of early plaque formation. 5. Topical cyclosporine (1%) drops have been recently reported to be effective in severe unresponsive cases.
B. Systemic therapy 1. Oral antihistaminics may provide some relief from itching in severe cases. 2. Oral steroids for a short duration have been recommended for advanced, very severe, nonresponsive cases.
C. Treatment of large papillae. Very large (giant) papillae can be tackled either by : _ Supratarsal injection of long acting steroid or _ Cryo application _ Surgical excision is recommended for extraordinarily large papillae.
D. General measures include : _ Dark goggles to prevent photophobia. _ Cold compresses and ice packs have soothing effects. _ Change of place from hot to cold area is recommended for recalcitrant cases.
E. Desensitization has also been tried without much rewarding results. F. Treatment of vernal keratopathy _ Punctate epithelial keratitis requires no extra treatment except that instillation of steroids should be increased. _ A large vernal plaque requires surgical excision by superficial keratectomy. _ Severe shield ulcer resistant to medical therapy may need surgical treatment in the form of debridment, superficial keratectomy, excimer laser therapeutic kerateotomy as well as amniotic membrane transplantation to enhance reepithelialization.